# Clamp Study Comparing Inhalation of Technosphere®/Insulin in Smokers and Non-Smokers With Type 2 Diabetes

> **NCT00934414** · PHASE2 · COMPLETED · sponsor: **Mannkind Corporation** · enrollment: 24 (actual)

## Conditions studied

- Diabetes Type 2

## Interventions

- **DRUG:** Technosphere Insulin Inhalation Powder

## Key facts

- **NCT ID:** NCT00934414
- **Lead sponsor:** Mannkind Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** 2006-08
- **Final completion:** 2006-09
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2009-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00934414

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00934414, "Clamp Study Comparing Inhalation of Technosphere®/Insulin in Smokers and Non-Smokers With Type 2 Diabetes". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00934414. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*